Cargando…
CD20 as a gatekeeper of the resting state of human B cells
CD20 is a B cell-specific membrane protein and represents an attractive target for therapeutic antibodies. Despite widespread usage of anti-CD20 antibodies for B cell depletion therapies, the biological function of their target remains unclear. Here, we demonstrate that CD20 controls the nanoscale o...
Autores principales: | Kläsener, Kathrin, Jellusova, Julia, Andrieux, Geoffroy, Salzer, Ulrich, Böhler, Chiara, Steiner, Sebastian N., Albinus, Jonas B., Cavallari, Marco, Süß, Beatrix, Voll, Reinhard E., Boerries, Melanie, Wollscheid, Bernd, Reth, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896350/ https://www.ncbi.nlm.nih.gov/pubmed/33563755 http://dx.doi.org/10.1073/pnas.2021342118 |
Ejemplares similares
-
B cell activation involves nanoscale receptor reorganizations and inside-out signaling by Syk
por: Kläsener, Kathrin, et al.
Publicado: (2014) -
Dysregulated PI3K Signaling in B Cells of CVID Patients
por: Harder, Ina, et al.
Publicado: (2022) -
Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells
por: He, Xiaocui, et al.
Publicado: (2018) -
TLR induces reorganization of the IgM-BCR complex regulating murine B-1 cell responses to infections
por: Savage, Hannah P, et al.
Publicado: (2019) -
Cationic porphyrins are tunable gatekeepers of the 20S proteasome
por: Santoro, Anna M., et al.
Publicado: (2016)